ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 177 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $200,000 | -22.5% | 3,332 | +8.9% | 0.01% | -16.7% |
| Q2 2019 | $258,000 | -11.6% | 3,060 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $292,000 | +34.6% | 3,060 | 0.0% | 0.01% | +16.7% |
| Q4 2018 | $217,000 | -16.9% | 3,060 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $261,000 | +7.0% | 3,060 | +45.2% | 0.01% | 0.0% |
| Q2 2018 | $244,000 | +42.7% | 2,108 | 0.0% | 0.01% | +20.0% |
| Q1 2018 | $171,000 | +643.5% | 2,108 | +210.0% | 0.01% | +400.0% |
| Q4 2016 | $23,000 | – | 680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |